HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancer.

AuthorsYeon Jeong Kim, Young Bin Hong, Chi Heum Cho, Yeon-Sun Seong, Insoo Bae
JournalPancreas (Pancreas) Vol. 41 Issue 5 Pg. 804-5 (Jul 2012) ISSN: 1536-4828 [Electronic] United States
PMID22695089 (Publication Type: Letter, Research Support, N.I.H., Extramural)
Chemical References
  • Antimetabolites, Antineoplastic
  • Protein Kinase Inhibitors
  • Deoxycytidine
  • Protein Kinases
  • Gemcitabine
Topics
  • Antimetabolites, Antineoplastic (administration & dosage, pharmacology)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Deoxycytidine (administration & dosage, analogs & derivatives, pharmacology)
  • Drug Resistance, Neoplasm (drug effects)
  • Drug Synergism
  • Humans
  • Pancreatic Neoplasms (drug therapy, metabolism, pathology)
  • Protein Kinase Inhibitors (administration & dosage, pharmacology)
  • Protein Kinases (metabolism)
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: